Document is current
Any future updates will be listed below
-
Authors
Rothman, Adam L.
Chang, Ta Chen
Lum, Flora
Vanner, Elizabeth A.
-
Funding
Funding for this research was provided by:
Research to Prevent Blindness (Unrestricted Departmental Grant)
Research to Prevent Blindness (Unrestricted Departmental Grant)
Research to Prevent Blindness (Unrestricted Departmental Grant)
National Eye Institute (P30EY013810)
National Eye Institute (P30EY013810)
National Eye Institute (P30EY013810)
Research to Prevent Blindess/American Academy of Ophthalmology, United States (2020 Award for IRIS® Registry Research)
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 13 August 2024
First Online: 17 August 2024
Competing interests
: This research was funded in part by Research to Prevent Blindness (New York, NY, USA)/American Academy of Ophthalmology (San Francisco, CA, USA) 2020 Award for IRIS Registry Research; NIH Center Core Grant (P30EY013810, Bethesda, MD, USA); Research to Prevent Blindness Unrestricted Grant (New York, NY, USA). The sponsor or funding organizations participated in the design of the study, conducting the research, data collection, data management, and review and approval of the manuscript. Dr. Lum is an employee of the American Academy of Ophthalmology. Dr Vanner is a stockholder for Greenlight Biosciences (Medford, MA, USA). Drs. Rothman, Chang, and Lum have no financial disclosures.
